chr14-39154294-CCT-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1_StrongPM2PP3_ModeratePP5_Moderate
The NM_001079537.2(TRAPPC6B):c.268-2_268-1del variant causes a splice acceptor change. The variant allele was found at a frequency of 0.0000174 in 1,605,614 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
TRAPPC6B
NM_001079537.2 splice_acceptor
NM_001079537.2 splice_acceptor
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.84
Genes affected
TRAPPC6B (HGNC:23066): (trafficking protein particle complex subunit 6B) TRAPPC6B is a component of TRAPP complexes, which are tethering complexes involved in vesicle transport (Kummel et al., 2005 [PubMed 16025134]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.1740042 fraction of the gene. Cryptic splice site detected, with MaxEntScore 5.6, offset of 18, new splice context is: acggcatctatgtacttcAGgac. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 14-39154294-CCT-C is Pathogenic according to our data. Variant chr14-39154294-CCT-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3255618.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRAPPC6B | NM_001079537.2 | c.268-2_268-1del | splice_acceptor_variant | ENST00000330149.10 | |||
TRAPPC6B | NM_177452.4 | c.268-2457_268-2456del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRAPPC6B | ENST00000330149.10 | c.268-2_268-1del | splice_acceptor_variant | 1 | NM_001079537.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151542Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151542
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245928Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133598
GnomAD3 exomes
AF:
AC:
3
AN:
245928
Hom.:
AF XY:
AC XY:
2
AN XY:
133598
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000172 AC: 25AN: 1454072Hom.: 0 AF XY: 0.0000152 AC XY: 11AN XY: 723690
GnomAD4 exome
AF:
AC:
25
AN:
1454072
Hom.:
AF XY:
AC XY:
11
AN XY:
723690
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151542Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73982
GnomAD4 genome
AF:
AC:
3
AN:
151542
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
73982
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India | - | In-silico analysis tools suchas SpliceAI predict the variant to cause aberrant splicing. The variant c.268-2_268-1del was previouslyreported in four patients from the same family (Almousa et al. 2024). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: 0
Find out detailed SpliceAI scores and Pangolin per-transcript scores at